Literature DB >> 23234823

Congenital malaria in a European country.

Ana Rita Prior1, Filipa Prata, Ana Mouzinho, José Gonçalo Marques.   

Abstract

A newborn of 26 days, born in Lisbon, Portugal, presented with fever, anaemia and thrombocytopaenia. She was admitted considering neonatal sepsis, but Plasmodium vivax was identified in the second peripheral blood smear performed. Parenteral quinine was started with good evolution. Despite clinicians' unfamiliarity with congenital malaria in non-endemic areas, this diagnosis, although rare, should not be forgotten in the evaluation of newborns/infants born to women from endemic areas or with recent trip to these areas.

Entities:  

Mesh:

Year:  2012        PMID: 23234823      PMCID: PMC4544039          DOI: 10.1136/bcr-2012-007310

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

Review 1.  Congenital infections associated with international travel during pregnancy.

Authors:  Lauren M McGovern; Thomas G Boyce; Philip R Fischer
Journal:  J Travel Med       Date:  2007 Mar-Apr       Impact factor: 8.490

Review 2.  A recent case of congenital malaria in Singapore.

Authors:  W W Lee; M Singh; C L Tan
Journal:  Singapore Med J       Date:  1996-10       Impact factor: 1.858

3.  Congenital Plasmodium vivax malaria mimicking neonatal sepsis: a case report.

Authors:  Veronica Del Punta; Maurizio Gulletta; Alberto Matteelli; Vania Spinoni; Antonio Regazzoli; Francesco Castelli
Journal:  Malar J       Date:  2010-03-01       Impact factor: 2.979

4.  [Congenital Malaria. Case reports and a brief review of literature].

Authors:  H H Marques; M G Vallada; P T Sakane; M Boulos
Journal:  J Pediatr (Rio J)       Date:  1996 Mar-Apr       Impact factor: 2.197

5.  Treatment and prevention of malaria in pregnancy and newborn.

Authors:  Oriol Coll; Clara Menendez; Francesc Botet; Rajeshwar Dayal; Xavier Carbonell-Estrany; Leonard E Weisman; Mauricio M Anceschi; Anne Greenough; Ronald S Gibss; Yves Ville
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.